LEMAITRE VASCULAR, INC. Payments to Acquire Productive Assets
LEMAITRE VASCULAR, INC. (LMAT) reported Payments to Acquire Productive Assets of $5.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for the quarter ending 2026-06-30 was $2.31M, a 72.35% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for the quarter ending 2026-03-31 was $2.78M, a 101.23% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for the quarter ending 2025-12-31 was $1.78M, a 13.06% decline year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for the quarter ending 2025-09-30 was $2.28M, a 36.59% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for fiscal 2025 was $6.78M, a 2.57% decline from fiscal 2024.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for fiscal 2024 was $6.96M, a 4.17% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for fiscal 2023 was $7.26M, a 124.99% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. payments to acquire productive assets for fiscal 2022 was $3.23M, a 33.86% decline from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.10M 10-Q · filed 2026-08-05 | $6.87M derived: sum of 3 quarters · filed 2026-08-05 | $9.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.78M 10-Q · filed 2026-05-06 | $4.56M derived: sum of 2 quarters · filed 2026-05-06 | $6.84M derived: sum of 3 quarters · filed 2026-05-06 | $8.18M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.06M derived: sum of 2 quarters · filed 2026-02-26 | $5.40M derived: sum of 3 quarters · filed 2026-08-05 | $6.78M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.62M derived: sum of 2 quarters · filed 2026-08-05 | $5.01M 10-Q · filed 2025-11-07 | $7.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.73M 10-Q · filed 2026-08-05 | $4.77M derived: sum of 3 quarters · filed 2026-08-05 | $6.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.38M 10-Q · filed 2026-05-06 | $3.43M derived: sum of 2 quarters · filed 2026-05-06 | $5.10M derived: sum of 3 quarters · filed 2026-05-06 | $6.97M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.71M derived: sum of 2 quarters · filed 2026-02-26 | $5.59M derived: sum of 3 quarters · filed 2026-02-26 | $6.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.55M derived: sum of 2 quarters · filed 2025-11-07 | $4.92M 10-Q · filed 2025-11-07 | $6.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.25M 10-Q · filed 2025-08-06 | $4.53M derived: sum of 3 quarters · filed 2026-02-26 | $5.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.37M 10-Q · filed 2025-05-08 | $2.65M derived: sum of 2 quarters · filed 2026-02-26 | $3.70M derived: sum of 3 quarters · filed 2026-02-26 | $6.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.33M derived: sum of 2 quarters · filed 2026-02-26 | $5.13M derived: sum of 3 quarters · filed 2026-02-26 | $7.26M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $3.86M derived: sum of 2 quarters · filed 2024-11-08 | $5.99M 10-Q · filed 2024-11-08 | $7.25M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.93M 10-Q · filed 2024-08-08 | $6.19M derived: sum of 3 quarters · filed 2025-02-28 | $6.65M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.13M 10-Q · filed 2024-05-10 | $3.39M derived: sum of 2 quarters · filed 2025-02-28 | $3.85M derived: sum of 3 quarters · filed 2025-02-28 | $4.82M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.72M derived: sum of 2 quarters · filed 2025-02-28 | $2.69M derived: sum of 3 quarters · filed 2025-02-28 | $3.23M 10-K · filed 2025-02-28 |
| 2022-09-30 | $460.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.43M derived: sum of 2 quarters · filed 2023-11-07 | $1.97M 10-Q · filed 2023-11-07 | $2.58M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $973.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.51M 10-Q · filed 2023-08-08 | $2.12M derived: sum of 3 quarters · filed 2024-02-29 | $3.93M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $536.00K 10-Q · filed 2023-05-09 | $1.14M derived: sum of 2 quarters · filed 2024-02-29 | $2.96M derived: sum of 3 quarters · filed 2024-02-29 | $4.36M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.42M derived: sum of 2 quarters · filed 2024-02-29 | $3.82M derived: sum of 3 quarters · filed 2024-02-29 | $4.88M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.22M derived: sum of 2 quarters · filed 2022-11-08 | $4.28M 10-Q · filed 2022-11-08 | $5.49M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.46M 10-Q · filed 2022-08-05 | $3.68M derived: sum of 3 quarters · filed 2023-03-01 | $4.27M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $1.06M 10-Q · filed 2022-05-10 | $2.27M derived: sum of 2 quarters · filed 2023-03-01 | $2.87M derived: sum of 3 quarters · filed 2023-03-01 | $3.18M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.81M derived: sum of 2 quarters · filed 2023-03-01 | $2.12M derived: sum of 3 quarters · filed 2023-03-01 | $2.98M 10-K · filed 2023-03-01 |
| 2020-09-30 | $593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $904.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.77M 10-Q · filed 2021-11-04 | $3.17M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.17M 10-Q · filed 2021-08-05 | $2.57M derived: sum of 3 quarters · filed 2022-02-28 | $3.28M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $863.00K 10-Q · filed 2021-05-10 | $2.26M derived: sum of 2 quarters · filed 2022-02-28 | $2.97M derived: sum of 3 quarters · filed 2022-02-28 | $3.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.11M derived: sum of 2 quarters · filed 2022-02-28 | $2.96M derived: sum of 3 quarters · filed 2022-02-28 | $3.76M 10-K · filed 2022-02-28 |
| 2019-09-30 | $710.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.56M derived: sum of 2 quarters · filed 2020-11-06 | $2.36M 10-Q · filed 2020-11-06 | $3.65M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $849.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.65M 10-Q · filed 2020-08-06 | $2.94M derived: sum of 3 quarters · filed 2021-03-12 | $3.48M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $802.00K 10-Q · filed 2020-05-08 | $2.09M derived: sum of 2 quarters · filed 2021-03-12 | $2.63M derived: sum of 3 quarters · filed 2021-03-12 | $3.43M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.82M derived: sum of 2 quarters · filed 2021-03-12 | $2.63M derived: sum of 3 quarters · filed 2021-03-12 | $3.05M 10-K · filed 2021-03-12 |
| 2018-09-30 | $534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.34M derived: sum of 2 quarters · filed 2019-11-08 | $1.76M 10-Q · filed 2019-11-08 | $3.40M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $803.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.23M 10-Q · filed 2019-08-06 | $2.87M derived: sum of 3 quarters · filed 2020-03-12 | $5.20M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $427.00K 10-Q · filed 2019-05-06 | $2.06M derived: sum of 2 quarters · filed 2020-03-12 | $4.40M derived: sum of 3 quarters · filed 2020-03-12 | $5.15M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $3.97M derived: sum of 2 quarters · filed 2020-03-12 | $4.73M derived: sum of 3 quarters · filed 2020-03-12 | $6.42M 10-K · filed 2020-03-12 |
| 2017-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $3.09M derived: sum of 2 quarters · filed 2018-11-02 | $4.78M 10-Q · filed 2018-11-02 | $5.79M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $2.44M 10-Q · filed 2018-08-06 | $3.46M derived: sum of 3 quarters · filed 2019-03-11 | |
| 2017-03-31 | $1.69M 10-Q · filed 2018-05-04 | $2.70M derived: sum of 2 quarters · filed 2019-03-11 | ||
| 2016-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $2.84M 10-K · filed 2019-03-11 | ||
| 2016-09-30 | $1.83M 10-Q · filed 2017-11-03 | |||
| 2015-12-31 | $2.27M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |